Business Description
Cipla Ltd
ISIN : US1729771006
Share Class Description:
CPLFY: DRTotal Employee Number:
47,496Compare
Compare
Traded in other countries / regions
500087.IndiaCIPLA.Luxembourg IPO Date
2011-03-02Description
Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 16.34 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.1 | |||||
Interest Coverage | 86.67 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 11.23 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.2 | |||||
3-Year EBITDA Growth Rate | 7.2 | |||||
3-Year EPS without NRI Growth Rate | 11.5 | |||||
3-Year FCF Growth Rate | -25.2 | |||||
3-Year Book Growth Rate | 13.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.38 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 10.31 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.44 | |||||
Quick Ratio | 2.5 | |||||
Cash Ratio | 1.43 | |||||
Days Inventory | 234.42 | |||||
Days Sales Outstanding | 79.15 | |||||
Days Payable | 115.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 37.5 | |||||
Shareholder Yield % | 0.82 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.54 | |||||
Operating Margin % | 17.01 | |||||
Net Margin % | 14 | |||||
EBITDA Margin % | 23.42 | |||||
ROE % | 11.81 | |||||
ROA % | 9.69 | |||||
ROIC % | 13.43 | |||||
3-Year ROIIC % | 9.21 | |||||
ROC (Joel Greenblatt) % | 36.18 | |||||
ROCE % | 15.64 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 30.01 | |||||
PE Ratio without NRI | 28.25 | |||||
Shiller PE Ratio | 37.41 | |||||
Price-to-Owner-Earnings | 32.25 | |||||
PEG Ratio | 2.55 | |||||
PS Ratio | 4.2 | |||||
PB Ratio | 3.38 | |||||
Price-to-Tangible-Book | 4.22 | |||||
Price-to-Free-Cash-Flow | 135.25 | |||||
Price-to-Operating-Cash-Flow | 29.55 | |||||
EV-to-EBIT | 20.28 | |||||
EV-to-EBITDA | 16.49 | |||||
EV-to-Revenue | 3.86 | |||||
EV-to-FCF | 124.35 | |||||
Price-to-Projected-FCF | 1.94 | |||||
Price-to-DCF (Earnings Based) | 1.64 | |||||
Price-to-DCF (FCF Based) | 10.31 | |||||
Price-to-Median-PS-Value | 1.18 | |||||
Price-to-Peter-Lynch-Fair-Value | 2 | |||||
| Price-to-Net-Current-Asset-Value | 7.23 | |||||
| Price-to-Net-Cash | 59.25 | |||||
Earnings Yield (Greenblatt) % | 4.93 | |||||
FCF Yield % | 0.74 | |||||
Forward Rate of Return (Yacktman) % | 13.18 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:CPLFY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cipla Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0.22 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0 - 0 | ||
| Shares Outstanding (Mil) | 807.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cipla Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cipla Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-10-30 16:00 | In 125 days | ||
| Second quarter earnings results for 2027 | 2026-10-30 | In 124 days | ||
| First quarter earnings conference call for 2027 | 2026-07-24 15:00 | In 27 days | ||
| First quarter earnings results for 2027 | 2026-07-24 | In 26 days | ||
| General meeting for 2026 | 2026-06-25 14:00 | -- | ||
| Annual report for 2026 | 2026-06-01 | -- | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-13 16:00 | -- | ||
| Fourth quarter earnings results for 2026 | 2026-05-13 | -- | ||
| Third quarter earnings conference call for 2026 | 2026-01-23 16:00 | -- | ||
| Third quarter earnings results for 2026 | 2026-01-23 | -- |
Show
Entries
Cipla Ltd Frequently Asked Questions
What is Cipla Ltd(CPLFY)'s stock price today?
The current price of CPLFY is $0.00. The 52 week high of CPLFY is $0.00 and 52 week low is $0.00.
When is next earnings date of Cipla Ltd(CPLFY)?
The next earnings date of Cipla Ltd(CPLFY) is 2026-07-24 Est..
Does Cipla Ltd(CPLFY) pay dividends? If so, how much?
Cipla Ltd(CPLFY) does not pay dividend.
Guru Commentaries on OTCPK:CPLFY
No articles.
Press Release
Articles on Cipla Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers